Challenges in CNS drug development and the role of imaging

被引：0
作者：
Oliver D. Howes
Mitul A. Mehta
机构：
[1] King’s College London,Institute of Psychiatry, Psychology and Neuroscience
[2] Hammersmith Hospital,MRC London Institute for Medical Sciences
[3] H Lundbeck A/S,Translational Neuropsychiatry
来源：
Psychopharmacology | 2021年 / 238卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1229 / 1230
页数：1
相关论文
共 50 条
  • [31] The current development of CNS drug research
    Wegener, Gregers
    Rujescu, Dan
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2013, 16 (07) : 1687 - 1693
  • [32] Phosphodiesterases in the CNS: targets for drug development
    Frank S. Menniti
    W. Stephen Faraci
    Christopher J. Schmidt
    Nature Reviews Drug Discovery, 2006, 5 : 660 - 670
  • [33] Phosphodiesterases in the CNS: targets for drug development
    Menniti, Frank S.
    Faraci, W. Stephen
    Schmidt, Christopher J.
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (08) : 660 - 670
  • [34] The utility of biomarkers in CNS drug development
    Palmer, Alan M.
    DRUG DISCOVERY TODAY, 2014, 19 (03) : 201 - 203
  • [35] CNS Drug Development - Lost in Translation?
    Talevi, A.
    Bellera, C. L.
    Di Ianni, M.
    Gantner, M.
    Bruno-Blanch, L. E.
    Castro, E. A.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2012, 12 (10) : 959 - 970
  • [36] Gold Nanoparticles for Imaging and Drug Transport to the CNS
    Male, D.
    Gromnicova, R.
    McQuaid, C.
    INTERNATIONAL REVIEW OF NEUROBIOLOGY, VOL 130: NANOTECHNOLOGY AND THE BRAIN, 2016, 130 : 155 - 198
  • [37] Molecular imaging in drug development: Update and challenges for radiolabeled antibodies and nanotechnology
    Colombo, Ilaria
    Overchuk, Marta
    Chen, Juan
    Reilly, Raymond M.
    Zheng, Gang
    Lheureux, Stephanie
    METHODS, 2017, 130 : 23 - 35
  • [38] Challenges of Imaging as a Biomarker in Drug Research and Drug
    Miyoshi, Sosuke
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2014, 134 (04): : 465 - 472
  • [39] Reporter gene imaging and its role in imaging-based drug development
    Shaikh, Faiq A.
    Kurtys, Ewelina
    Kubassova, Olga
    Roettger, Diana
    DRUG DISCOVERY TODAY, 2020, 25 (03) : 582 - 592
  • [40] Advances in CNS PET: the state-of-the-art for new imaging targets for pathophysiology and drug development
    McCluskey, Stuart P.
    Plisson, Christophe
    Rabiner, Eugenii A.
    Howes, Oliver
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (02) : 451 - 489
12345